Sun Pharma posts Q4 & FY17 results
In Q4FY17 the consolidated sales / income from operations was at Rs 6,825 crores
Author
Glenmark receives ANDA approval for Olmesartan Medoxomil tabs
The tablets will be manufactured at its Goa facility Glenmark Pharmaceuticals has been granted final approval by the US FDA for…
Govt rolls out fruit-flavoured TB tablets for children
The initiative has been rolled out in five states and by next month, it will be introduced in 17 more states Children suffering…
Pharma industry welcomes GST move, expects better rates
By Swati Rana-Mumbai Further clarifications are needed before it comes into force The much awaited Goods and Services Tax (GST)…
Strides Shasun posts Q4 FY17 and H2 FY 17 results
The company achieved 95 per cent of the guidance with H2 FY 17 EBITDA at Rs 4,200 million despite a challenging operating…
VWR enters into definitive agreement with Avantor
The agreement will create a vertically integrated, global player in manufacturing and supply chain solutions for the life…
CPhI Worldwide Advisory Board inducts five new global experts
The board will help to steer the overall development of CPhI events and content CPhI Worldwide, organised by UBM EMEA, has…
Marksans Pharma receives GMP certificate
TGA, Department of Health, Australia issued the certificate for its Verna facility in Goa Drug firm Marksans Pharma has received…
Piramal Enterprises partners with IPA
Piramal Enterprises and IPA jointly will organise Chemist Awareness Programmes in different locations across India and chemists…
Clarivate Analytics unveils ‘India Innovation: Trends’ report
Pharma contributed 15 per cent of the total patents published in the top 10 DWPI categories in India